Gastroenterology News

BOSTON — Healio spoke with James L. Boyer, MD, FACEP, about interim results from the phase 2a INTEGRIS-PSC trial presented at The Liver Meeting, which showed bexotegrast reduced biomarkers of liver fibrosis vs. placebo.

Senior physicians cared for fewer patients in underrepresented racial and ethnic groups as well as those with Medicaid compared with their junior colleagues within the same practice, a study published in JAMA Network Open found.

BOSTON — Healio spoke with James L. Boyer, MD, FACEP, about research assessing the role of Claudin-1 in cholangiocarcinoma, which was presented at The Liver Meeting.

Medications that target bile acid-triggered pathways and combination therapies could be the key for treating nonalcoholic steatohepatitis for young people with obesity and type 2 diabetes, according to a speaker.

Asian patients with hepatocellular carcinoma had the lowest waitlist dropout rates and highest 5-year survival after liver transplantation before and after the policy change, while Black or African American patients had the worst outcomes.

BOSTON — In this video, Norah Terrault, MD, MPH, FAASLD, spoke with Healio about a presentation from The Liver Meeting on “The Toronto Protocol,” an ultra-short course of glecaprevir/pibrentasvir with ezetimibe.

A risk-advancement period approach using sex and polygenic risk score helped identify starting ages for colorectal cancer screening, with men reaching an equivalent risk for CRC occurrence and mortality at a younger age than women.

BOSTON — In this video, Norah Terrault, MD, MPH, FAASLD, discusses findings from an abstract at The Liver Meeting, which estimated the prevalence of hepatitis C virus infection in the United States between 2017 and 2020.

BOSTON — Healio spoke with Norah Terrault, MD, MPH, FAASLD, about presentations from The Liver Meeting that investigated testing and treatment of hepatitis C virus infection among pregnant individuals.

As we approach the year end, many investors, including physicians, will review their portfolios and assess the last 12 months of performance.